By Seth Nelson, Senior Director of Operations, WCG ThreeWire
Selecting the right site is the single most crucial decision you’ll make about your next clinical trial. And perhaps the single most important consideration in selecting a site is whether it can make its enrollment. Many don’t; in fact, 20-25 percent of all clinical studies close because they fail to meet enrollment targets.1
The startup process is often more complicated than either sponsors or sites anticipate. Research2 from March 2018 finds that:
- Average time from site identification to study start-up completion is 31.4 weeks; that’s a month longer than 10 years ago.
- On average, 11 percent of investigative sites initiated were never activated; what’s more, that figure hasn’t changed in 20 years.